Quintiles Launches Continuous Glucose Monitoring Services
The new offering, designed to enhance diabetes trials, combines wearable technology with Quintiles' therapeutic and analytical expertise.
Quintiles announced a new service offering designed to improve diabetes-focused clinical trials. Through the solution, continuous glucose measurements will be monitored by a wearable sensor and wirelessly sent to a receiver, recording readings throughout the day. In the clinical trial setting, such comprehensive and timely glucose visibility can potentially improve patient safety, accelerate clinical development, and provide a basis for differentiated claims.
Read the full release here
Truqap Combination Shines in Phase III Trial for Prostate Cancer
November 26th 2024Data from the CAPItello-281 trial show Truqap alongside abiraterone and androgen deprivation therapy achieved a statistically significant and clinically meaningful improvement in radiographic progression-free survival.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
